Evidence map›Paper›PMID 28248223›Full record

ReviewProteomes2016

Mass Spectrometric Immunoassays in Characterization of Clinically Significant Proteoforms.

Olgica Trenchevska, Randall W Nelson, Dobrin Nedelkov

Abstract readReview
In one paragraph

Review in Proteomes, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Diagnostic Value of Synovial Fluid Biomarkers for Periprosthetic Joint Infection: A Prospective, Double-blind Trial.Medical science monitor : international medical journal of experimental and clinical research · 2023
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Omics era in forensic medicine: towards a new ageTurkish journal of medical sciences · 2020
    Review
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Olgica TrenchevskaThe Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA. olgica.trenchevska@asu.edu.
Randall W NelsonThe Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA. randal.nelson@asu.edu.
Dobrin NedelkovThe Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA. dobrin.nedelkov@asu.edu.

Funding

Team Approach to Translate Novel Biomarkers for DiabetesR24DK090958 · NIDDK · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI NELSON, RANDALL W, PEARSON, JAMES DAVID · 2011 to 2014
$4.5M
Population-Based Proteomic Investigation of Type 2 Diabetes MellitusR01DK082542 · NIDDK · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI NELSON, RANDALL W · 2010 to 2014
$3.0M
NIDDK NIH HHS R01 DK082542NIDDK NIH HHS R24 DK090958
6 · The paper itself

Abstract

Proteins can exist as multiple proteoforms

Indexed as

biomarkersimmunoaffinitymass spectrometryposttranslational modificationstop-down analysis

Identifiers

PMID28248223
PMCPMC5217360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.